Cargando…
Cardioprotection in right heart failure
Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characteriz...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680005/ https://www.ncbi.nlm.nih.gov/pubmed/31995639 http://dx.doi.org/10.1111/bph.14992 |
_version_ | 1783612375424827392 |
---|---|
author | Boengler, Kerstin Schlüter, Klaus‐Dieter Schermuly, Ralph Theo Schulz, Rainer |
author_facet | Boengler, Kerstin Schlüter, Klaus‐Dieter Schermuly, Ralph Theo Schulz, Rainer |
author_sort | Boengler, Kerstin |
collection | PubMed |
description | Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characterized, cardioprotection of the right ventricle is principally feasible but less established. Similar to what is known for the left ventricle, a dysregulation in signalling pathways seems to play a role in I/R injury of the healthy and failing right ventricle and in the ability/inability of the right ventricle to respond to a conditioning stimulus. The maintenance of mitochondrial function seems to be crucial in both ventricles to reduce I/R injury. As far as currently known, similar molecular mechanisms mediate ischaemic and pharmacological preconditioning in the left and right ventricles. However, the two ventricles seem to respond differently towards exercise‐induced preconditioning. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc |
format | Online Article Text |
id | pubmed-7680005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76800052020-11-27 Cardioprotection in right heart failure Boengler, Kerstin Schlüter, Klaus‐Dieter Schermuly, Ralph Theo Schulz, Rainer Br J Pharmacol Review Articles Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characterized, cardioprotection of the right ventricle is principally feasible but less established. Similar to what is known for the left ventricle, a dysregulation in signalling pathways seems to play a role in I/R injury of the healthy and failing right ventricle and in the ability/inability of the right ventricle to respond to a conditioning stimulus. The maintenance of mitochondrial function seems to be crucial in both ventricles to reduce I/R injury. As far as currently known, similar molecular mechanisms mediate ischaemic and pharmacological preconditioning in the left and right ventricles. However, the two ventricles seem to respond differently towards exercise‐induced preconditioning. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc John Wiley and Sons Inc. 2020-03-09 2020-12 /pmc/articles/PMC7680005/ /pubmed/31995639 http://dx.doi.org/10.1111/bph.14992 Text en © 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Boengler, Kerstin Schlüter, Klaus‐Dieter Schermuly, Ralph Theo Schulz, Rainer Cardioprotection in right heart failure |
title | Cardioprotection in right heart failure |
title_full | Cardioprotection in right heart failure |
title_fullStr | Cardioprotection in right heart failure |
title_full_unstemmed | Cardioprotection in right heart failure |
title_short | Cardioprotection in right heart failure |
title_sort | cardioprotection in right heart failure |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680005/ https://www.ncbi.nlm.nih.gov/pubmed/31995639 http://dx.doi.org/10.1111/bph.14992 |
work_keys_str_mv | AT boenglerkerstin cardioprotectioninrightheartfailure AT schluterklausdieter cardioprotectioninrightheartfailure AT schermulyralphtheo cardioprotectioninrightheartfailure AT schulzrainer cardioprotectioninrightheartfailure |